WHITNEY HERSH: Open Payments
NPI 1972055507 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 69 payments from 18 companies in 2025. Trend: 2023 $1,916 · 2024 $680 · 2025 $1,660
Food & beverage: $1,477Education: $183
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $412 |
| Janssen Biotech, Inc. | 11 | $365 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $200 |
| Incyte Corporation | 6 | $138 |
| UCB, Inc. | 4 | $107 |
| Galderma Laboratories, L.P. | 4 | $65 |
| Botanix SB Inc | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Lilly USA, LLC | 2 | $41 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
Products named: TREMFYA, RINVOQ, OPZELURA, SKYRIZI, Bimzelx, ILUMYA, SOFDRA, DUPIXENT.
Industry payments across IL — which companies pay providers there.
